The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients

It is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienc...

Full description

Bibliographic Details
Main Authors: Nataliya V. Dolgushina, Irina V. Menzhinskaya, Daria M. Ermakova, Natalia A. Frankevich, Valentina V. Vtorushina, Gennady T. Sukhikh
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/13/4370
_version_ 1797591396751769600
author Nataliya V. Dolgushina
Irina V. Menzhinskaya
Daria M. Ermakova
Natalia A. Frankevich
Valentina V. Vtorushina
Gennady T. Sukhikh
author_facet Nataliya V. Dolgushina
Irina V. Menzhinskaya
Daria M. Ermakova
Natalia A. Frankevich
Valentina V. Vtorushina
Gennady T. Sukhikh
author_sort Nataliya V. Dolgushina
collection DOAJ
description It is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienced COVID-19 (group 2) in a mild (n = 85) or moderate (n = 50) form less than 12 months prior to oocyte retrieval. Using ELISAs, the profiles of their serum autoantibodies were determined, including antiphospholipid antibodies and antibodies to nuclear and thyroid antigens. The parameters of oogenesis and embryogenesis, as well as the pregnancy and childbirth rates, did not differ between groups 1 and 2, and also between the subgroups with different severities of COVID-19. However, when oocyte retrieval was performed less than 180 days after COVID-19, a higher proportion of poor-quality blastocysts was obtained (<i>p</i> = 0.006). A high risk of early miscarriage was found in the patients with moderate COVID-19. In group 2, IgG antibodies to annexin V, phosphatidylethanolamine (PE), and TSHr were detected more often than in group 1 (<i>p</i> = 0.035; <i>p</i> = 0.028; and <i>p</i> = 0.033, respectively), and a weak inverse correlation was revealed between anti-PE IgG and the number of oocytes and zygotes obtained. The results of the study suggest a possible adverse effect of COVID-19 and its associated autoantibodies on the outcomes of fresh oocyte ART cycles and early pregnancy, which depends on the severity of COVID-19 and the time interval after the disease.
first_indexed 2024-03-11T01:36:49Z
format Article
id doaj.art-16a93fe564c54a86a56496a9bf377c59
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T01:36:49Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-16a93fe564c54a86a56496a9bf377c592023-11-18T16:52:55ZengMDPI AGJournal of Clinical Medicine2077-03832023-06-011213437010.3390/jcm12134370The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated PatientsNataliya V. Dolgushina0Irina V. Menzhinskaya1Daria M. Ermakova2Natalia A. Frankevich3Valentina V. Vtorushina4Gennady T. Sukhikh5National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of the Russian Federation, 117997 Moscow, RussiaIt is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienced COVID-19 (group 2) in a mild (n = 85) or moderate (n = 50) form less than 12 months prior to oocyte retrieval. Using ELISAs, the profiles of their serum autoantibodies were determined, including antiphospholipid antibodies and antibodies to nuclear and thyroid antigens. The parameters of oogenesis and embryogenesis, as well as the pregnancy and childbirth rates, did not differ between groups 1 and 2, and also between the subgroups with different severities of COVID-19. However, when oocyte retrieval was performed less than 180 days after COVID-19, a higher proportion of poor-quality blastocysts was obtained (<i>p</i> = 0.006). A high risk of early miscarriage was found in the patients with moderate COVID-19. In group 2, IgG antibodies to annexin V, phosphatidylethanolamine (PE), and TSHr were detected more often than in group 1 (<i>p</i> = 0.035; <i>p</i> = 0.028; and <i>p</i> = 0.033, respectively), and a weak inverse correlation was revealed between anti-PE IgG and the number of oocytes and zygotes obtained. The results of the study suggest a possible adverse effect of COVID-19 and its associated autoantibodies on the outcomes of fresh oocyte ART cycles and early pregnancy, which depends on the severity of COVID-19 and the time interval after the disease.https://www.mdpi.com/2077-0383/12/13/4370COVID-19SARS-CoV-2autoantibodiesinfertilityassisted reproductive technologyreproductive outcomes
spellingShingle Nataliya V. Dolgushina
Irina V. Menzhinskaya
Daria M. Ermakova
Natalia A. Frankevich
Valentina V. Vtorushina
Gennady T. Sukhikh
The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
Journal of Clinical Medicine
COVID-19
SARS-CoV-2
autoantibodies
infertility
assisted reproductive technology
reproductive outcomes
title The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
title_full The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
title_fullStr The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
title_full_unstemmed The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
title_short The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients
title_sort effect of covid 19 severity associated serum autoantibodies and time interval after the disease on the outcomes of fresh oocyte art cycles in non vaccinated patients
topic COVID-19
SARS-CoV-2
autoantibodies
infertility
assisted reproductive technology
reproductive outcomes
url https://www.mdpi.com/2077-0383/12/13/4370
work_keys_str_mv AT nataliyavdolgushina theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT irinavmenzhinskaya theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT dariamermakova theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT nataliaafrankevich theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT valentinavvtorushina theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT gennadytsukhikh theeffectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT nataliyavdolgushina effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT irinavmenzhinskaya effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT dariamermakova effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT nataliaafrankevich effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT valentinavvtorushina effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients
AT gennadytsukhikh effectofcovid19severityassociatedserumautoantibodiesandtimeintervalafterthediseaseontheoutcomesoffreshoocyteartcyclesinnonvaccinatedpatients